Answers are grounded in this paper and cite their sources.
Reproductive concerns are common among patients with cancer and can affect psychological well-being, treatment decisions, and quality of life. Although several Patient-Reported Outcome Measures (PROMs) have been developed to assess these concerns, their measurement properties have not been systematically evaluated, and no instrument is universally accepted as the gold standard. This systematic review therefore aimed to identify PROMs assessing reproductive concerns in patients with cancer and to evaluate their measurement properties using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines. We conducted a systematic review of PROMs assessing reproductive concerns among patients with cancer following the COSMIN guidelines. “A comprehensive search was conducted in nine electronic databases: PubMed, Embase, Web of Science, Scopus, Cochrane, China National Knowledge Infrastructure (CNKI), Cumulative Index to Nursing and Allied Health Literature (CINAHL), WanFang, and ProQuest.” Searches covered the period from the database inception to August 1, 2025. This review included 22 studies that evaluated 10 PROMs, including abbreviated or modified versions of these 10 scales; the overall count of PROMs addressing reproductive concerns increased to 20 measurement tools, and 10,323 participants. The global quality of evidence for most PROMs measurement properties was poor. All included studies evaluated ≥ 1 psychometric property of the included PROMs. An adequate number of reproductive concerns domains were assessed by the Reproductive Concerns After Cancer Scale (RCAC), Reproductive Concerns After Cancer Scale-Male(RCACM), Fertility Problem Inventory༈FPI༉, Fertility Problem Inventory-Short Form༈FPI-SF༉, Fertility Information Support Scale༈FISS༉, Fertility Intention Scale༈FIS༉, Revision of a Fertility Intention Scale༈RFIS༉, Reproductive Concerns of Female Cancer Survivors༈RCS༉, and Modified Reproductive Concerns Scale༈MRCS༉and RS-PROM. RCAC demonstrated the strongest evidence for sufficient psychometric data on a wide range of measurement properties. Compared with the other nine PROMs, the RCAC has undergone the most comprehensive evaluation of its measurement properties and demonstrated satisfactory reliability and validity, supporting its provisional recommendation for use in patients with cancer. However, further validation of additional measurement properties is warranted. PROSPERO (CRD420251106493).
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: